List of Colazal drug patents

Colazal is owned by Valeant Pharms Intl.

Colazal contains Balsalazide Disodium.

Colazal has a total of 4 drug patents out of which 0 drug patents have expired.

Colazal was authorised for market use on 18 July, 2000.

Colazal is available in capsule;oral dosage forms.

Colazal can be used as treatment of ulcerative colitis.

The generics of Colazal are possible to be released after 24 February, 2027.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7625884 VALEANT PHARMS INTL Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives
Aug, 2026

(3 years from now)

US7452872 VALEANT PHARMS INTL Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives
Aug, 2026

(3 years from now)

US7625884

(Pediatric)

VALEANT PHARMS INTL Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives
Feb, 2027

(4 years from now)

US7452872

(Pediatric)

VALEANT PHARMS INTL Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives
Feb, 2027

(4 years from now)

Drugs and Companies using BALSALAZIDE DISODIUM ingredient

Market Authorisation Date: 18 July, 2000

Treatment: Treatment of ulcerative colitis

Dosage: CAPSULE;ORAL

How can I launch a generic of COLAZAL before it's patent expiration?
More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in